CytomX Therapeutics, Inc. 4
4 · CytomX Therapeutics, Inc. · Filed Dec 31, 2015
Insider Transaction Report
Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2015-12-31−8,917→ 76,688 totalExercise: $6.61Exp: 2025-08-25→ Common Stock (8,917 underlying) - Exercise/Conversion
Common Stock
2015-12-31$6.61/sh+8,917$58,983→ 13,917 total
Footnotes (1)
- [F1]This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month.